NCT03603093

Brief Summary

Esophagogastroduodenoscopy (EGD) become more and more common in diagnosing gastroenterology diseases. The investigators want to find which symptoms can support for positive endoscopic findings through this multicenter study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,287

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 18, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 27, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

December 24, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2019

Completed
Last Updated

November 18, 2021

Status Verified

November 1, 2021

Enrollment Period

8 months

First QC Date

July 18, 2018

Last Update Submit

November 16, 2021

Conditions

Digestive System AbnormalitiesEndoscopy

Keywords

EsophagogastroduodenoscopyPaediatric

Outcome Measures

Primary Outcomes (1)

  • Quantities of every indications for esophagogastroduodenoscopic procedures collected from questionaire finished by clinical doctor

    Indications for esophagogastroduodenoscopic procedures were collected through questionaire, including abdominal pain, vomiting, and so on.

    from August 15th to October 15th in 2018

Eligibility Criteria

Age1 Day - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All of the patients need esophagogastroduodenoscopic procedures

You may qualify if:

  • All of the patients need esophagogastroduodenoscopic procedures

You may not qualify if:

  • Patients whose parents reject to provide information for study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's hospital of Fudan Universtity

Shanghai, China

Location

Related Publications (1)

  • Wang S, Qiu X, Chen J, Mei H, Yan H, You J, Huang Y. Pediatric esophagogastroduodenoscopy in china: indications, diagnostic yield, and factors associated with findings. BMC Pediatr. 2022 Sep 2;22(1):522. doi: 10.1186/s12887-022-03558-x.

    PMID: 36056317DERIVED

MeSH Terms

Conditions

Digestive System Abnormalities

Condition Hierarchy (Ancestors)

Digestive System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Ying Huang, doctor

    Children's Hospital of Fudan University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
The director of gastroenterology of Children's Hospital of Fudan University

Study Record Dates

First Submitted

July 18, 2018

First Posted

July 27, 2018

Study Start

December 24, 2018

Primary Completion

August 30, 2019

Study Completion

October 30, 2019

Last Updated

November 18, 2021

Record last verified: 2021-11

Locations

CN(1)